CA
NZ
UK
AU
IND
US
French biotech Abivax’s $920 million cash infusion is reshaping investor expectations in the healthcare sector, particularly for mid-stage drug developers. The funding removes the company’s immediate need for a buyer or partner to launch its therapy in the U.S. A move that could pressure …
Annovis Bio, Inc. (NYSE: ANVS) disclosed that its pivotal Phase 3 trial of buntanetap in early Alzheimer’s disease has reached full enrollment. The company reported that 850 patients meeting pTau217 criteria have been enrolled, marking a key development milestone.
Travel nurses working under 1099 contracts often overlook powerful retirement savings tools designed for independent workers. Without a Solo 401(k), these professionals may forfeit the chance to reduce taxable income while building a nest egg. The structure of 1099 work creates unique financial planning …
Travere Therapeutics has outlined a succession plan within its finance organization, designating John Torell as the forthcoming chief accounting officer. This move follows the announced retirement of Sandra Calvin, who presently holds the chief accounting officer role.
Traws Pharma (NASDAQ: TRAW) secured shareholder approval to expand its 2021 Incentive Compensation Plan by 2,000,000 shares. The amendment, which took effect following the vote, increases the pool of common stock available for equity-based awards to employees and executives. This adjustment aligns with the …
Iovance Biotherapeutics’ strong quarterly results are energizing the broader biotech environment, prompting investors to reconsider exposure to firms advancing personalized cell‑based therapies. The combination of share price appreciation and revenue acceleration underscores market enthusiasm for novel melanoma approaches and may bolster interest in companies …
Medline Inc. (NASDAQ: MDLN) reported a senior leadership change on July 9, 2026. The company said its Chief Operating Officer, Stephen L. Miller, will step down due to health reasons, with the exit slated for August 30, 2026.
Medline Inc. (NASDAQ: MDLN) reported a senior leadership change on July 9, 2026. The company said its Chief Operating Officer, Stephen L. Miller, will step down due to health reasons, with the exit slated for August 30, 2026.
NEXGEL, INC. Has announced a delay for its 2026 Annual Meeting of Stockholders, shifting the date from July 10 to July 31, 2026. This decision aims to provide the company with additional time to gather necessary proxies for an array of proposals scheduled for …
Nurix Therapeutics, Inc. (NASDAQ: NRIX) has announced its quarterly financial results, providing insight into the company's performance. The results are a key indicator of the company's progress in the healthcare sector. The announcement was made on July 9, 2026.
Please wait processing your request...